Advertisement Abbott to invest $270m in Ohio nutrition manufacturing facility - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Abbott to invest $270m in Ohio nutrition manufacturing facility

Abbott has announced plans to invest $270m to construct a nutrition manufacturing facility in Tipp City, Ohio, in April 2012.

The new plant, which will produce Ensure and Glucerna for the North America market, is expected to become operational in late 2013.

The new manufacturing facility will specialize in aseptic packaging technology, the company said.

Abbott Global Nutrition executive vice president John Landgraf said the new plant will enable the company to meet the demand for its adult liquid nutrition products, Ensure and Glucerna.

"It will be a key addition to our global manufacturing network that will allow the company to gain important operational efficiencies," Landgraf added.